Accenture explores $1.5B sale of China business, taps JPMorgan

Accenture is exploring a sale of its Greater China business, a deal that could value the unit at up to $1.5 billion, according to the Financial Times. The consulting giant has hired JPMorgan to run a strategic review of the unit, the report said, citing people familiar with the matter. The review is reportedly in its early stages, and no final decision has been made, but the involvement of a top-tier investment bank signals that Accenture is serious about an exit.

For a firm that generated roughly $64 billion in global revenue last fiscal year, a $1.5 billion valuation for its Greater China operations is a modest but meaningful piece of the puzzle. It is also a striking admission of how much the calculus has changed for Western professional services firms operating in China. Accenture has been in the market for decades, serving multinational clients and local champions alike. But the geopolitical and regulatory environment has shifted dramatically. Beijing's tightening grip on data flows, the escalating tech war with Washington, and a slowing domestic economy have made China a harder place to do business for foreign consultancies. In recent years, China has introduced data localization rules, export controls, and national security reviews that complicate cross-border consulting work. These measures have made it harder for firms to move data and talent in and out of the country, and they have raised the compliance cost of every engagement.

The sale process, if it proceeds, would mark one of the most high-profile exits by a global consulting firm from China. It would also be a test of appetite for such assets. Potential buyers could include local consulting firms looking to acquire scale, private equity funds seeking a platform in the region, or even Chinese state-linked entities. JPMorgan's involvement suggests the process will be competitive, and the $1.5 billion price tag will set a benchmark for how other Western firms value their China units. The buyer could also be a consortium of investors looking to create a standalone China-focused consulting firm, though no specific bidders have been named.

For Accenture, the logic is clear. The consulting industry as a whole has been pivoting toward cloud, data, and AI, and Accenture has been at the forefront of that shift, making a China exit less painful for its growth narrative. A sale of the China unit would free up capital and management attention, while also removing a source of geopolitical risk. It would also allow Accenture to avoid the kind of entanglements that have plagued other Western firms, from forced technology transfers to compliance with China's new anti-espionage laws. The company has been aggressively expanding in markets like India, Southeast Asia, and the Middle East, and a China exit would let it double down on those priorities without the distraction of a politically sensitive market.

But the move is not without costs. China remains a critical market for many of Accenture's global clients, and a local presence is often a prerequisite for winning work there. By selling, Accenture risks ceding ground to local competitors like Huawei's consulting arm or domestic firms such as Roland Berger's Chinese operations. It also sends a signal to the Chinese government that Western professional services are retreating, which could further strain commercial ties. For multinational clients that rely on Accenture to navigate China's complex regulatory landscape, the sale could create uncertainty about who will serve them going forward.

The broader implication is for every multinational with a China strategy. Accenture's decision, if confirmed, will be read as a data point in the ongoing decoupling of the world's two largest economies. For boards and CEOs, it raises a difficult question: if a firm as sophisticated as Accenture is willing to walk away from China, what is your own exposure worth? The answer will depend on industry, regulatory risk, and the ability to operate independently of Beijing's priorities. The move also puts pressure on other global consultancies, which may now face investor questions about why they are not taking similar steps.

For now, the review is just that - a review. The Financial Times report does not specify a timeline, and Accenture could still decide to keep the unit. But the fact that JPMorgan has been brought in suggests the company is not just testing the waters; it is preparing to swim. Rival consultancies, private equity firms, and corporate strategists will be watching closely to see who steps forward and at what price. The outcome will shape not only Accenture's footprint but also the broader market for China-focused professional services assets.

The takeaway for executives is straightforward: China exposure is no longer a static asset on the balance sheet. It is a live risk that needs constant repricing. Accenture's $1.5 billion number is a starting point for that conversation, and every global firm should have its own version of that number ready. Whether you are a buyer, a seller, or a bystander, the message is clear: the era of easy China expansion for Western professional services is over.